The world of spinal care continues to be divided among the slow-growing giants like Johnson & Johnson (NYSE:JNJ), Medtronic (NYSE:MDT), and Stryker (NYSE:SYK) and the much faster-growing up-and-comers like NuVasive (NASDAQ:NUVA) and Globus Medical (NYSE:GMED). With Globus maintaining a focus on continuous product development and new launches and the expansion of its sales effort, the growth prospects continue to look good, particularly as some industry headwinds appear to be abating.
Valuation for med-tech has gotten trickier as the stocks have been quite strong over the last year or so. Globus isn't so appealing from the viewpoint of intrinsic value (discounted cash flow), but the stock doesn't seem overpriced from the...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|